Thursday, October 17, 2024
HomeNEWSFrost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting...

Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value, and Proven Ability to Expedite Quality Clinical Programs, Business News

Avance Clinical streamlines its biotech clients’ clinical trial operations, workflows, and data management, optimizing study efficiencies, minimizing costs, and accelerating trial timelines. SAN ANTONIO, Aug. 27, 2024 /PRNewswire/ — Frost & Sullivan recently assessed the biotech contract research organization (CRO) industry and, based on its results, recognizes Avance Clinical with the 2024 Global Customer Value
Read More

RELATED ARTICLES

Most Popular